M&A activity in the North American healthcare sector for Q3 2013 was down 24% from last quarter, with 409 deals announced or closed in the period according to data provided by S&P Capital IQ. Deal count however, remained on the uptick, adding 26 deals quarter over quarter. The pharmaceutical sector continued to see the biggest deals with Amgen’s $10.4 billion purchase of Onyx Pharmaceuticals leading the pack as the quarter’s largest deal. Vendors racked up the most deals. Two of the five largest vendor deals involved private equity investors purchasing electronic medical record companies.
